{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:30:02Z","timestamp":1780605002971,"version":"3.54.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["neurotox res"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/bf03033283","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:23:34Z","timestamp":1248110614000},"page":"469-475","source":"Crossref","is-referenced-by-count":45,"title":["Stress kinases involved inTau phosphorylation in alzheimer\u2019s disease, tauopathies and APP transgenic mice"],"prefix":"10.1007","volume":"6","author":[{"given":"I.","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03033283_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/bss0670073","volume":"67","author":"BH Anderton","year":"2001","unstructured":"Anderton BH, J Betts, WP Blackstock, JP Brion, S Chapman, J Connell, R Dayanandan, JM Gallo, G Gibb, DP Hanger, M Hutton, E Kardalinou, K Leroy, S Lovestone, T Mack, CH Reynolds and M van Slegtenhorst (2001) Sites of phosphorylation intau and factors affecting their regulation.Biochem. Soc. Symp. 67, 73\u201380.","journal-title":"Biochem. Soc. Symp."},{"key":"BF03033283_CR2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/jnen\/60.12.1190","volume":"60","author":"C Atzori","year":"2001","unstructured":"Atzori C, B Ghetti, R Piva, AN Srinivasan, P Zolo, MB Delisle, SS Mirra and A Migheli (2001) Activation of the JNK\/p38 pathway occurs in diseases characterized bytau protein pathology and is related totau phosphorylation but not to apoptosis.J. Neuropathol. Exp. Neurol. 60, 1190\u20131197.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1385\/MN:25:3:213","volume":"25","author":"J Avila","year":"2002","unstructured":"Avila J, F Lim, F Moreno, C Belmonte and AC Cuello (2002)Ta u function and dysfunction in neurons, its role in neurodegenera-tive disorders.Mol. Neurobiol. 25, 213\u2013231.","journal-title":"Mol. Neurobiol."},{"key":"BF03033283_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0301-0082(98)00055-0","volume":"57","author":"C Behl","year":"1999","unstructured":"Behl C (1999) AD and oxidative stress, implications for novel therapeutic approaches.Progr. Neurobiol. 57, 301\u2013323.","journal-title":"Progr. Neurobiol."},{"key":"BF03033283_CR5","first-page":"40","volume-title":"Neurodegeneration, the Molecular Pathology of Dementia and Movement Disorders","author":"L Bertram","year":"2003","unstructured":"Bertram L and R Tanzi (2003) Genetics of Alzheimer\u2019s disease, In:Neurodegeneration, the Molecular Pathology of Dementia and Movement Disorders (Dickson D, Ed.) (ISN. Neuropath. Press, Basel), pp 40\u201346."},{"key":"BF03033283_CR6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-4886(03)00252-8","volume":"184","author":"V Blanchard","year":"2003","unstructured":"Blanchard V, S Moussaoui, C Czech, N Touchet, B Bonici, M Planche, T Canton, I Jedidi, M Gohin, O Wirths, TA Bayer, D Langui, C Duyckaerts, G Tremp and L Pradier (2003) Time sequence of maturation of dystrophic neurites associated with A\u00df deposits in APP\/PS1 transgenic mice.Exp. Neurol. 184, 247\u2013263.","journal-title":"Exp. Neurol."},{"key":"BF03033283_CR7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt DR, T Ratovitsi, J van Lare, MK Lee, V Gozales, NA Jenkins, NG Copeland, DL Price and SS Sisodia (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.Neuron 19, 939\u2013945.","journal-title":"Neuron"},{"key":"BF03033283_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1471-4159.2001.00294.x","volume":"77","author":"D Bozyczko-Coyne","year":"2001","unstructured":"Bozyczko-Coyne D, TM O\u2019Kane, ZL Wu, P Dobrzanski, S Murphy, JL Vaught and RW Scott (2001) CEP-1347\/KT-7515, an inhibitor of SAPK\/JNK pathway activity, promotes survival and blocks multiple events associated with A\u00df-induced cortical neuron apoptosis.J. Neurochem. 77, 849\u2013863.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(02)02460-2","volume":"515","author":"V Bu\u00e9e-Scherrer","year":"2002","unstructured":"Bu\u00e9e-Scherrer V and M Goedert (2002) Phosphorylation of micro-tubule-associated proteintau by stress-activated protein kinases in intact cells.FEBS Lett. 515, 151\u2013154.","journal-title":"FEBS Lett."},{"key":"BF03033283_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L, T Bussi\u00e8re, V Bu\u00e9e-Scherrer, A Delacourte and PR Hof (2000) Tau protein isoforms, phosphorylation and role in neu-rodegenerative disorders.Brain Res. Rev. 33, 95\u2013130.","journal-title":"Brain Res. Rev."},{"key":"BF03033283_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1012541011123","volume":"16","author":"WM Daniels","year":"2001","unstructured":"Daniels WM, J Hendricks, R Salie and JJ Taljaard (2001) The role of MAP-kinase superfamily in \u00df-amyloid toxicity.Metab. Brain Dis. 16, 175\u2013185.","journal-title":"Metab. Brain Dis."},{"key":"BF03033283_CR12","first-page":"47","volume-title":"Neurodegeneration, the Molecular Pathology of Dementia and Movement Disorders","author":"C Duyckaerts","year":"2003","unstructured":"Duyckaerts C and DW Dickson (2003) Neuropathology of Alzheimer\u2019s disease, In,Neurodegeneration, the Molecular Pathology of Dementia and Movement Disorders (Dickson D, Ed.) (ISN Neuropath. Press, Basel), pp 47\u201368."},{"key":"BF03033283_CR13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s007020100016","volume":"108","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, R Blanco, M Carmona and B Puig (2001a) Phosphorylated mitogen-activated protein kinase (MAPK\/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK\/JNK-P), and calcium\/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed intau deposits in neurons and glial cells intauopathies.J. Neural Transm. 108, 1397\u20131415.","journal-title":"J. Neural Transm."},{"key":"BF03033283_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2990.2001.00348.x","volume":"27","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, R Blanco, M Carmona and B Puig (2001b) Phosphorylated c-Myc expression in Alzheimer disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration.Neuropathol. Appl. Neurobiol. 27, 343\u2013351.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BF03033283_CR15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1750-3639.2001.tb00387.x","volume":"11","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, R Blanco, M Carmona, R Ribera, E Goutan, B Puig, MJ Rey, A Cardozo, F Vi\u00f1als and T Ribalta (2001c) Phosphorylated MAP kinase (ERK1, ERK2) expression is associated with earlytau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration.Brain Pathol. 11, 144\u2013158.","journal-title":"Brain Pathol."},{"key":"BF03033283_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1750-3639.2003.tb00007.x","volume":"13","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, M Barrachina, M Tolnay, MJ Rey, N Vidal, M Carmona, R Blanco and B Puig (2003a) Phosphorylated protein kinases associated with neuronal and glialtau deposits in argyrophilic grain disease.Brain Pathol. 13, 62\u201378.","journal-title":"Brain Pathol."},{"key":"BF03033283_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2990.2003.00435.x","volume":"29","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, P Pastor, MJ Rey, E Mu\u00f1oz, B Puig, E Pastor, R Oliva and E Tolosa (2003b) Tau phosphorylation and kinase activation in familialtauopathy linked to delN296 mutation.Neuropathol. Appl. Neurobiol. 29, 23\u201334.","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BF03033283_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","volume":"14","author":"I Ferrer","year":"2004","unstructured":"Ferrer I, M Boada-Rovira, ML Sanchez-Guerra, MJ Rey and F Costa-Jussa (2004a) Neuropathology and pathogenesis of encephalitis following amyloid-\u00df immunization in Alzheimer\u2019s disease.Brain Pathol. 14, 11\u201320.","journal-title":"Brain Pathol."},{"key":"BF03033283_CR19","doi-asserted-by":"crossref","unstructured":"Ferrer I, I Hernandez, B Puig, MJ Rey, M Ezquerra, E Tolosa and M Boada (2004b) Ubiquitin-negative mini-Pick-like bodies in the dentate gyrus in P301Ltauopathy.J. Alzheimer Dis. (in press).","DOI":"10.3233\/JAD-2003-5604"},{"key":"BF03033283_CR20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/bj20021660","volume":"371","author":"MP Fogarty","year":"2003","unstructured":"Fogarty MP, EJ Downer and V Campbell (2003) A role for c-Jun N-terminal kinase 1 (JNK-1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apop-totic cascade in cultured cortical neurons.Biochem. J. 371, 789\u2013798.","journal-title":"Biochem. J."},{"key":"BF03033283_CR21","first-page":"357","volume":"146","author":"A Furuta","year":"1995","unstructured":"Furuta A, DL Price, CA Pardo, JC Troncoso, ZS Xu, N Taniguchi and LJ Martin (1995) Localization of superoxide dismutases in Alzheimer\u2019s disease and Down\u2019s syndrome neocortex and hippocampus.Am. J. Pathol. 146, 357\u2013362.","journal-title":"Am. J. Pathol."},{"key":"BF03033283_CR22","first-page":"704","volume":"349","author":"D Games","year":"1995","unstructured":"Games D, D Adams, R Alessandrini, R Barbour, P Berthelette, C Blackwell, T Carr, J Clemens, T Donaldson and F Gillespie (1995) Alzheimer-type neuropathology in transgenic mice over-expressing V717F beta-amyloid precursor protein.Nature 349, 704\u2013706.","journal-title":"Nature"},{"key":"BF03033283_CR23","first-page":"86","volume-title":"Neurodegeneration, The Molecular Pathology of Dementia and Movement Disorders","author":"B Ghetti","year":"2003","unstructured":"Ghetti B, ML Hutton and ZK Wszolek (2003) Frontotemporal dementia and parkinsonism linked to chromosome 17 associated withtau gene mutations (FTDP-17T), In:Neurodegeneration, The Molecular Pathology of Dementia and Movement Disorders (Dickson D, Ed.) (ISN. Neuropath. Press, Basel), pp 86\u2013102."},{"key":"BF03033283_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(97)00483-3","volume":"409","author":"M Goedert","year":"1997","unstructured":"Goedert M, M Hasegawa, R Jakes, S Lawler, A Cuenda and P Cohen (1997) Phosphorylation of microtubule-associated proteintau by stress-activated protein kinases.FEBS Lett. 409, 57\u201362.","journal-title":"FEBS Lett."},{"key":"BF03033283_CR25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/jnr.10525","volume":"71","author":"A Gomez-Ramos","year":"2003","unstructured":"Gomez-Ramos A, J Diaz-Nido, MA Smith, G Perry and J Avila (2003) Effect of the lipid peroxidation product acrolein ontau phosphorylation in neural cells.J. Neurosci. Res. 71, 863\u2013870.","journal-title":"J. Neurosci. Res."},{"key":"BF03033283_CR26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0197-4580(02)00029-5","volume":"23","author":"AW Hartzler","year":"2002","unstructured":"Hartzler AW, X Zhu, SL Siedlak, RJ Castellani, J Avila, G Perry and MA Smith (2002) The p38 pathway is activated in Pick disease and progressive supranuclear palsy, a mechanistic link between mitogenic pathways, oxidative stress andtau.Neurobiol. Aging 23, 855\u2013859.","journal-title":"Neurobiol. Aging"},{"key":"BF03033283_CR27","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1471-4159.1999.0722053.x","volume":"72","author":"K Hensley","year":"1999","unstructured":"Hensley K, RA Floyd, NY Zheng, R Nael, KA Robinson, X Nguyen, QN Pye, CA Stewart, J Geddes, WR Markesbery, E Patel, GV Johnson and G Bing (1999) p38 kinase is activated in the Alzheimer\u2019s disease brain.J. Neurochem. 72, 2053\u20132058.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35017105","volume":"2","author":"A Herreman","year":"2000","unstructured":"Herreman A, L Serneels, W Annaert, D Collen, L Schoonjans and B De Strooper (2000) Total inactivation of ?-secretase activity in presenilin-deficient embryonic stem cells.Nat. Cell Biol. 2, 461\u2013462.","journal-title":"Nat. Cell Biol."},{"key":"BF03033283_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","volume":"4","author":"L Holcomb","year":"1998","unstructured":"Holcomb L, MN Gordon, E McGowan, X Yu, S Benkovic, P Janyzen, K Wright, I Saad, R Mueller, D Morgan, S Sanders, C Zehr, K O\u2019Campo, J Hardy, CM Prada, C Eckman, S Younkin, K Hsiao and K Duff (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenelin 1 transgenes.Nat. Med. 4, 97\u2013100.","journal-title":"Nat. Med."},{"key":"BF03033283_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, P Chapman, S Nilsen, C Exkman, Y Harigaya, S Younkin, F Yang and G Cole (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.Science 274, 99\u2013102.","journal-title":"Science"},{"key":"BF03033283_CR31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1471-4914(02)02440-1","volume":"8","author":"EM Ingram","year":"2002","unstructured":"Ingram EM and MG Spillantini (2002)Ta u gene mutations, dissecting the pathogenesis of FTDP-17.Trends Mol. Med. 8, 556\u2013562.","journal-title":"Trends Mol. Med."},{"key":"BF03033283_CR32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","volume":"56","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, M McNamara, K Fedorchak, K Hsia and BT Hyman (1997a) APPSw transgenic mice develop age-related A\u00df deposits and neuropil abnormalities, but no neuronal loss in CA1.J. Neuropathol. Exp. Neurol. 56, 965\u2013973.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR33","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1523\/JNEUROSCI.17-18-07053.1997","volume":"17","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, F Soriano, M McNamara, KJ Page, D Schenk, D Games and BT Hyman (1997b) A\u00df deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.J. Neurosci. 17, 7053\u20137059.","journal-title":"J. Neurosci."},{"key":"BF03033283_CR34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1749-6632.2002.tb04639.x","volume":"973","author":"JH Jang","year":"2002","unstructured":"Jang JH and YJ Surth (2002) \u00df-amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase.Ann. NY Acad. Sci. 973, 228\u2013236.","journal-title":"Ann. NY Acad. Sci."},{"issue":"2","key":"BF03033283_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/bj3450263","volume":"345","author":"SM Jenkins","year":"2000","unstructured":"Jenkins SM, M Zinnerman, C Garner and GV Johnson (2000) Modulation oftau phosphorylation and intracellular localization by cellular stress.Biochem. J. 345 part 2, 263\u2013270.","journal-title":"Biochem. J."},{"key":"BF03033283_CR36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00005072-199910000-00007","volume":"58","author":"RB Knowles","year":"1999","unstructured":"Knowles RB, J Chin, CT Ruff and BT Hyman (1999) Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibril-lary tangles, implications for MAP kinase activation in Alzheimer\u2019s disease.J. Neuropathol. Exp. Neurol. 58, 1090\u20131098.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR37","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.17-13-05089.1997","volume":"17","author":"I Kruman","year":"1997","unstructured":"Kruman I, AJ Bruce-Keller, D Brdeesen, G Waeg and MP Mattson (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci.17, 5089\u20135100.","journal-title":"J. Neurosci."},{"key":"BF03033283_CR38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"MVY Lee","year":"2001","unstructured":"Lee MVY, M Goedert and JQ Trojanowski (2001) Neurodegenerativetauopathies.Annu. Rev. Neurosci. 24, 1121\u20131159.","journal-title":"Annu. Rev. Neurosci."},{"key":"BF03033283_CR39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(96)00577-5","volume":"78","author":"S Lovestone","year":"1997","unstructured":"Lovestone S and CH Reynolds (1997) The phosphorylation oftau: a critical stage in neurodevelopment and neurodegenerative processes.Neuroscience 78, 309\u2013324.","journal-title":"Neuroscience"},{"key":"BF03033283_CR40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","volume":"68","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, MA Lowell, WR Markesbery, K Uchida and MP Mattson (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid \u00df-peptide.J. Neurochem. 68, 255\u2013264.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","volume":"9","author":"WR Markesberry","year":"1999","unstructured":"Markesberry WR and JM Carney (1999) Oxidative alterations in Alzheimer\u2019s disease.Brain Pathol. 9, 133\u2013146.","journal-title":"Brain Pathol."},{"key":"BF03033283_CR42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnen\/60.4.357","volume":"60","author":"E Masliah","year":"2001","unstructured":"Masliah E, A Sisk, M Mallory and D Games (2001) Neurofibrillary pathology in transgenic mice overexpressing V717F \u00df-amyloid precursor protein.J. Neuropathol. Exp. Neurol. 60, 357\u2013368.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR43","first-page":"74","volume-title":"Neurodegeneration, The Molecular Pathology of Dementia and Movement Disorders","author":"E McGowan","year":"2003","unstructured":"McGowan E, F Pickord and DW Dickson (2003) Alzheimer animal models, models of A\u00df deposition in transgenic mice, In:Neurodegeneration, The Molecular Pathology of Dementia and Movement Disorders (Dickson D, Ed.) (ISN. Neuropath. Press, Basel), pp 74\u201379."},{"key":"BF03033283_CR44","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1523\/JNEUROSCI.21-19-07551.2001","volume":"21","author":"Y Morishima","year":"2001","unstructured":"Morishima Y, Y Gotoh, J Zieg, T Barrett, H Takano, R Flavell, RJ Davis, Y Shirasaki and ME Greenberg (2001) \u00df-amyloid induces neuronal apopotosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.J. Neurosci. 21, 7551\u20137560.","journal-title":"J. Neurosci."},{"key":"BF03033283_CR45","first-page":"4448","volume":"9","author":"JAR Nicoll","year":"2003","unstructured":"Nicoll JAR, D Wilkinson, C Holmes, O Steart, H Markham and RO Weller (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-\u00df peptide, a case report.Nat. Med. 9, 4448\u20134452.","journal-title":"Nat. Med."},{"key":"BF03033283_CR46","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","volume":"19","author":"A Nunomura","year":"1999","unstructured":"Nunomura A, G Perry, MA Papolla, R Wade, K Hirai, S Ciba and MA Smith (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease.J. Neurosci. 19, 1959\u20131964.","journal-title":"J. Neurosci."},{"key":"BF03033283_CR47","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, G Perry, G Aliev, K Hiari, A Takeda, EK Balraj, PK Jones, H Ghanbari, T Wataya, S Shimohama, S Chiba, CS Atwood, RB Petersen and MA Smith (2001) Oxidative damage is the earliest event in Alzheimer\u2019s disease.J. Neuropathol. Exp. Neurol. 60, 759\u2013767.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR48","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/sj.onc.1202749","volume":"18","author":"AJ Obaya","year":"1999","unstructured":"Obaya AJ, MK Mateyak and JM Sedivy (1999) Mysterious liaisons, the relationship between c-Myc and the cell cycle.Oncogene 18, 2934\u20132941.","journal-title":"Oncogene"},{"key":"BF03033283_CR49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jnen\/59.5.393","volume":"59","author":"P Odetti","year":"2000","unstructured":"Odetti P, S Garibaldi, R Norese, G Angelini, L Marinelli, S Valentini, S Menini, N Traverso, D Zaccheo, S Siedlak, G Perry, MA Smith and M Tabaton (2000) Lipoperxidation is selectively involved in progressive supranuclear palsy.J. Neuropathol. Exp. Neurol. 59, 393\u2013397.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR50","first-page":"621","volume":"140","author":"MA Pappolla","year":"1992","unstructured":"Pappolla MA, RA Omar, KS Kim and NK Robakis (1992) Immunohistochemical evidence of oxidative stress in Alzheimer\u2019s disease.Am. J. Pathol. 140, 621\u2013628.","journal-title":"Am. J. Pathol."},{"key":"BF03033283_CR51","first-page":"871","volume":"152","author":"MA Pappolla","year":"1998","unstructured":"Pappolla MA, YJ Chyan, RA Omar, K Hsiao, G Perry, MA Smith and P Bozner (1998) Evidence of oxidative stress andin vivo neurotoxicity of \u00df-amyloid in a transgenic mouse model of Alzheimer\u2019s disease, a chronic oxidative paradigm for testing antioxidant therapiesin vivo.Am.. J. Pathol. 152, 871\u2013877.","journal-title":"Am.. J. Pathol."},{"key":"BF03033283_CR52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/JAD-2001-3107","volume":"3","author":"JJ Pei","year":"2001","unstructured":"Pei JJ, E Braak, H Braak, K Grundque-Iqbal, W Winblad and RF Cowburn (2001) Localization of active forms of c-Jun kinase (JNK) and p38 kinase in Alzheimer\u2019s disease brains at different stages of neurofibrillary degeneration.J. Alzheimer\u2019s Dis. 3, 41\u201348.","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"BF03033283_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-1998-1103","volume":"1","author":"G Perry","year":"1998","unstructured":"Perry G, RJ Castellani, K Hirai and MA Smith (1998) Reactive oxygen species mediate cellular damage in Alzheimer\u2019s disease.J. Alzheimer Dis. 1, 45\u201355.","journal-title":"J. Alzheimer Dis."},{"key":"BF03033283_CR54","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/00001756-199908020-00035","volume":"10","author":"G Perry","year":"1999","unstructured":"Perry G, H Roder, A Nunomura, A Takeda, AL Friedlich, X Zhu, AL Raina, N Holbrook, SL Siedlak, PLR Harris and MA Smith (1999) Activation of extracellular receptor kinase (ERK) in Alzheimer\u2019s disease links oxidative stress to abnormaltau phos-phorylation.NeuroReport 10, 2411\u20132415.","journal-title":"NeuroReport"},{"key":"BF03033283_CR55","doi-asserted-by":"crossref","unstructured":"Puig B, T G\u00f3mez-Isla, E Ribe, M Cuadrado and I Ferrer (2004a) Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK\/JNK-P) and p38 kinase (p38-P) links oxidative stress andtau hyperphosphorylation in neurites surrounding A\u00df plaques in APP Tg2576 mice.Neuropathol. Appl. Neurobiol. (in press).","DOI":"10.1111\/j.1365-2990.2004.00569.x"},{"key":"BF03033283_CR56","doi-asserted-by":"crossref","unstructured":"Puig B, F Vi\u00f1als and I Ferrer (2004b) Active stress kinase p38 enhances and perpetuates abnormaltau phosphorylation and deposition in Pick\u2019s disease.Acta Neuropathol. (in press).","DOI":"10.1007\/s00401-003-0793-z"},{"key":"BF03033283_CR57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1471-4159.1997.69010191.x","volume":"69","author":"CH Reynolds","year":"1997","unstructured":"Reynolds CH, AR Nebreda, GM Gibb, MA Utton and BH Anderton (1997a) Reactivating kinase\/p38 phosphorylatestau proteinin vitro.J. Neurochem. 69, 191\u2013198.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR58","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1471-4159.1997.68041736.x","volume":"68","author":"CH Reynolds","year":"1997","unstructured":"Reynolds CH, MA Utton, GM Gibb, A Yates and BH Anderton (1997b) Stress-activated protein kinase\/c-JunN-terminal kinase phosphorylatestau protein.J. Neurochem. 68, 1736\u20131744.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR59","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","volume":"74","author":"CH Reynolds","year":"2000","unstructured":"Reynolds CH, JC Betts, WP Blackstock, AR Nebreda and BH Anderton (2000) Phosphorylation sites ontau identified by nano-electrospray mass spectrometry, differencesin vitro between the mitogen-activated protein kinases ERK2, c-JunN-terminal kinase and p38, and glycogen synthase kinase-3\u00df.J. Neurochem. 74, 1587\u20131595.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR60","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1523\/JNEUROSCI.22-09-03376.2002","volume":"22","author":"MJ Savage","year":"2002","unstructured":"Savage MJ, YG Lin, JR Ciallella, DG Flood and RW Scott (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer\u2019s disease model is associated with amyloid deposition.J. Neurosci. 22, 3376\u20133385.","journal-title":"J. Neurosci."},{"key":"BF03033283_CR61","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00005072-199909000-00012","volume":"58","author":"LA Selznick","year":"1999","unstructured":"Selznick LA, DM Holtnman, BH Han, M G\u00f6kden, AN Srinavasan, EM Jonson and KA Roth (1999) In situ immunodetection of neu-ronal caspase-3 activation in Alzheimer\u2019s disease.J. Neuropathol. Exp. Neurol. 58, 1020\u20131026.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/374316b0","volume":"374","author":"MA Smith","year":"1995","unstructured":"Smith MA, LM Sayre, MP Vitek, VM Monnier and G Perry (1995) Early AGE in Alzheimer\u2019s disease.Nature 374, 316.","journal-title":"Nature"},{"key":"BF03033283_CR63","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1471-4159.1998.70052212.x","volume":"70","author":"MA Smith","year":"1998","unstructured":"Smith MA, K Hirai, K Hsiao, MA Pappolla, PL Harris, SL Siedlak, M Tabaton and G Perry (1998) Amyloid-\u00df deposition in Alzheimer transgenic mice is associated with oxidative stress.J. Neurochem. 70, 2212\u20132215.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR64","first-page":"139","volume":"1502","author":"MA Smith","year":"2000","unstructured":"Smith MA, CA Rottkamp, A Nunomura, AK Raina and G Perry (2000) Oxidative stress in Alzheimer\u2019s disease.Biochem. Biophys. Acta 1502, 139\u2013144.","journal-title":"Biochem. Biophys. Acta"},{"key":"BF03033283_CR65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0166-2236(98)01337-X","volume":"21","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG and M Goedert (1998)Ta u protein pathology in neurodegenerative diseases.Trends Neurosci. 21, 428\u2013433.","journal-title":"Trends Neurosci."},{"key":"BF03033283_CR66","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, D Abramowski, M Duke, KH Wiederhold, C Mistl, S Rothacher, B Ledermann, K Burki, P Frey, PA Paganetti, C Waridel, ME Calhoun, M Jucker, A Probst, M Staufenbiel and B Sommer (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.Proc. Natl. Acad. Sci. USA 94, 13287\u201313292.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03033283_CR67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0014-4886(03)00180-8","volume":"183","author":"A Sun","year":"2003","unstructured":"Sun A, M Liu, XV Nguyen and G Bing (2003) p38 MAP kinase is activated at early stages in Alzheimer\u2019s disease brain.Exp. Neurol. 183, 394\u2013405.","journal-title":"Exp. Neurol."},{"key":"BF03033283_CR68","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0014-4886(02)00059-6","volume":"180","author":"E Tamagno","year":"2003","unstructured":"Tamagno E, G Robino, A Obbili, P Bardini, M Aragno, M Parola and O Danni (2003) H2O2 and 4-hydroxynonenal mediate \u00df-amyloid-induced neuronal apoptosis by activating JNKs and p38 MAPKs.Exp. Neurol. 180, 144\u2013155.","journal-title":"Exp. Neurol."},{"key":"BF03033283_CR69","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","volume":"61","author":"T Togo","year":"2002","unstructured":"Togo T, N Sahara, SH Yen, N Cookson, T Ishizawa, M Hutton, R De Silva, A Lees and DW Dickson (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy.J. Neuropathol. Exp. Neurol. 61, 547\u2013556.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR70","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.897","volume":"194","author":"Y Tomidokoro","year":"2001","unstructured":"Tomidokoro Y, Y Harigaya, E Matsubara, M Ikeda, T Kawarabayashi, T Shirao, K Ishiguro, K Okamoto, SG Younkin and M Shoji (2001) Brain A\u00df amyloidosis in APP(Sw) mice induces accumulation of presenilin-1 andtau.J. Pathol. 194, 500\u2013506.","journal-title":"J. Pathol."},{"key":"BF03033283_CR71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1471-4159.2001.t01-1-00218.x","volume":"77","author":"CM Troy","year":"2001","unstructured":"Troy CM, SA Rabacchi, Z Xu, AC Maroney, TJ Connors, ML Shelanski and LA Greene (2001) Beta-amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.J. Neurochem. 77, 157\u2013164.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR72","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awf205","volume":"125","author":"W Wei","year":"2002","unstructured":"Wei W, DD Norton, X Wang and JW Kusiak (2002a) A\u00df 17-42 in Alzheimer\u2019s diseae actiavers JNK and caspase-8 leading to neu-ronal apoptosis.Brain 125, 2036\u20132043.","journal-title":"Brain"},{"key":"BF03033283_CR73","doi-asserted-by":"crossref","first-page":"17649","DOI":"10.1074\/jbc.M111704200","volume":"277","author":"W Wei","year":"2002","unstructured":"Wei W, X Wang and JW Kusiak (2002b) Signaling events in amyloid \u00df-peptide-induced neuronal death and insulin-like growth factor I protection.J. Biol. Chem. 277, 17649\u201317656.","journal-title":"J. Biol. Chem."},{"key":"BF03033283_CR74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/35017108","volume":"2","author":"Z Zhang","year":"2000","unstructured":"Zhang Z, P Nadeau, W Song, D Donoviel, M Yuan, A Bernstein and BA Yankner (2000) Presenilins are required for ?-secretase cleavage of \u00df-APP and transmembrane cleavage of Notch-1.Nat. Cell Biol. 2, 463\u2013465.","journal-title":"Nat. Cell Biol."},{"key":"BF03033283_CR75","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jnen\/59.10.880","volume":"59","author":"X Zhu","year":"2000","unstructured":"Zhu X, CA Rottkamp, H Boux, A Takeda, G Perry and MA Smith (2000) Activation of p38 kinase linkstau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.J. Neuropathol. Exp. Neurol. 59, 880\u2013888.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF03033283_CR76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0047-6374(01)00342-6","volume":"123","author":"X Zhu","year":"2001","unstructured":"Zhu X, RJ Castellani, A Takeda, A Nunomura, CS Atwood, G Perry and MA Smith (2001a) Differential activation of neuronal ERK, JNK\/SAPK and p38 in Alzheimer\u2019s disease, the two hit hypothesis.Mech. Ageing Dev. 123, 39\u201346.","journal-title":"Mech. Ageing Dev."},{"key":"BF03033283_CR77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00046.x","volume":"76","author":"X Zhu","year":"2001","unstructured":"Zhu X, AK Raina, CA Rottkamp, G Aliev, G Perry, H Boux and MA Smith (2001b) Activation and redistribution of c-Jun N-ter-minal kinase\/stress activated protein kinase in degenerating neurons in Alzheimer\u2019s disease.J. Neurochem. 76, 435\u2013441.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1471-4159.2001.00597.x","volume":"79","author":"X Zhu","year":"2001","unstructured":"Zhu X, CA Rottkamp, A Hartzler, Z Sun, A Takeda, H Boux, S Shimohama, G Perry and MA Smith (2001c) Activation of MKK6, an upstream activator of p38, in Alzheimer\u2019s disease.J. Neurochem. 79, 311\u2013318.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR79","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000067426","volume":"11","author":"X Zhu","year":"2002","unstructured":"Zhu X, HG Lee, AK Raina, G Perry and MA Smith (2002) The role of mitogen-activated protein kinase pathways in Alzheimer\u2019s disease.Neurosignals 11, 270\u2013281.","journal-title":"Neurosignals"},{"key":"BF03033283_CR80","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2003.01645.x","volume":"85","author":"X Zhu","year":"2003","unstructured":"Zhu X, O Ogawa, Y Wang, G Perry and MA Smith (2003a) JKK1, an upstream activator of JNK\/SAPK, is activated in Alzheimer\u2019s disease.J. Neurochem. 85, 87\u201393.","journal-title":"J. Neurochem."},{"key":"BF03033283_CR81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/152308603770310220","volume":"5","author":"X Zhu","year":"2003","unstructured":"Zhu X, AK Raina, HG Lee, M Chao, A Nunomura, M Tabaton, RB Petersen, G Perry and MA Smith (2003b) Oxidative stress and neuronal adaptation in Alzheimer disease, the role of SAPK pathways.Antioxid. Redox Signal 5, 571\u2013576.","journal-title":"Antioxid. Redox Signal"},{"key":"BF03033283_CR82","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1471-4159.2003.01820.x","volume":"86","author":"X Zhu","year":"2003","unstructured":"Zhu X, Z Sun, HG Lee, SL Siedlak, G Perry and MA Smith (2003c) Distribution, levels, and activation of MEK1 in Alzheimer\u2019s disease.J. Neurochem. 86, 136\u2013142.","journal-title":"J. Neurochem."}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03033283\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03033283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:32:15Z","timestamp":1558481535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03033283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF03033283"],"URL":"https:\/\/doi.org\/10.1007\/bf03033283","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}